• Commentary
  • Published April 2017

Polypharmacy in the elderly—when good drugs lead to bad outcomes: a teachable moment.

Geriatric patients are particularly vulnerable to adverse drug events due to comorbidities, complicated care plans, and polypharmacy. This commentary describes how using STOPP criteria and performing indication mapping can help reduce polypharmacy and improve patient safety.

Back to Top